Not logged in Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy Reply St-Laurent, Marie-Pier; Acland, George; Hamilton, Sarah N.; Hamm, Jeremy; Sunderland, Katherine; Black, Peter C.; McKenzie, Michael; Keyes, Mira; Miller, Stacy; Gleave, Martin E.; Tyldesley, Scott Share Save
Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy St-Laurent, Marie-Pier; Acland, George; Hamilton, Sarah N.; Hamm, Jeremy; Sunderland, Katherine; Black, Peter C.; McKenzie, Michael; Keyes, Mira; Miller, Stacy; Gleave, Martin E.; Tyldesley, Scott Share Save
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study Soleimani, Maryam; Zou, Kevin; Sunderland, Katherine; Struss, Werner; Eigl, Bernie J.; Nappi, Lucia; Kollmannsberger, Christian K.; Finch, Daygen; Noonan, Krista; Vergidis, Joanna; Zulfiqar, Muhammad; Chi, Kim N.; Khalaf, Daniel J. Share Save
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial Khalaf, Daniel J.; Sunderland, Katherine; Eigl, Bernhard J.; Kollmannsberger, Christian K.; Ivanov, Nikita; Finch, Daygen L.; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Gleave, Martin E.; Chi, Kim N. Share Save
Share Save
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer Annala, Matti; Vandekerkhove, Gillian; Khalaf, Daniel; Taavitsainen, Sinja; Beja, Kevin; Warner, Evan W.; Sunderland, Katherine; Kollmannsberger, Christian; Eigl, Bernhard J.; Finch, Daygen; Oja, Conrad D.; Vergidis, Joanna; Zulfiqar, Muhammad; Azad, Arun A.; Nykter, Matti; Gleave, Martin E.; Wyatt, Alexander W.; Chi, Kim N. Share Save
Share Save
Pain response in a Population-based study of Radium-223 for Metastatic Prostate Cancer Tyldesley, S.; Parimi, S.; Tsang, E.; Bachand, F.; Aparicio, M.; Duncan, G.; Sunderland, K.; Olson, R.; Pai, H.; Alexander, A.; Lapointe, V.; Chi, K. Share Save